Combination therapy for reducing the risks associated with cardiovascular disease
CA 2251972 A1 · Owner: Tobert, Jonathan A. · Inventors: Tobert, Jonathan A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The instant invention provides methods for preventing or reducing the risk of developing atherosclerosis as well as for halting or, slowing the progression of atherosclerotic disease once it has become clinically evident comprising the administration of a therapeutically effective amount of an HMG-CoA RI in combination with folic acid or a pharmaceutically acceptable salt or ester thereof to a person who is at risk of developing atherosclerosis or who already has atherosclerotic disease.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 14, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 14, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 14, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.